{
    "status": "ok",
    "totalResults": 2,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Rhenman & Partners Asset Management AB Purchases New Position in PROCEPT BioRobotics Co. (NASDAQ:PRCT)",
            "description": "Rhenman & Partners Asset Management AB bought a new position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT \u2013 Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institu\u2026",
            "url": "https://www.etfdailynews.com/2023/11/21/rhenman-partners-asset-management-ab-purchases-new-position-in-procept-biorobotics-co-nasdaqprct/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/procept-biorobotics-corp-logo.png?v=20211011093627&w=240&h=240&zc=2",
            "publishedAt": "2023-11-21T17:18:53Z",
            "content": "Rhenman &amp; Partners Asset Management AB bought a new position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT \u2013 Free Report) during the 2nd quarter, according to the company in its most recent 1\u2026 [+5084 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "PROCEPT BioRobotics Co. (NASDAQ:PRCT) Given Average Recommendation of \u201cBuy\u201d by Analysts",
            "description": "Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT \u2013 Get Free Report) have earned an average recommendation of \u201cBuy\u201d from the six research firms that are currently covering the firm, MarketBeat Ratings reports. Six research analysts have rated the stock with a bu\u2026",
            "url": "https://www.etfdailynews.com/2023/11/11/procept-biorobotics-co-nasdaqprct-given-average-recommendation-of-buy-by-analysts/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/procept-biorobotics-corp-logo.png?v=20211011093627&w=240&h=240&zc=2",
            "publishedAt": "2023-11-11T11:18:38Z",
            "content": "Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT \u2013 Get Free Report) have earned an average recommendation of \u201cBuy\u201d from the six research firms that are currently covering the firm, MarketBeat Ratings r\u2026 [+4050 chars]"
        }
    ]
}